Vision-Ease Lens and Schering-Plough HealthCare Products, Inc., a subsidiary of Merck & Co., Inc. have renewed their license agreement granting VEL exclusive rights to sell COPPERTONE polarized prescription lenses. Although launched less than three years ago, COPPERTONE polarized lenses have made substantial in-roads into the marketplace, and are now sold in more than 7,500 optical stores.
“Vision-Ease Lens appreciates the opportunity to continue to work with such an outstanding sun protection brand,” said Jay Lusignan, marketing communications manager at VEL. “Our customers value the brand messaging and the ease of communicating the sun protection message to their patients. We look forward to many years of partnership.”
In continued support of COPPERTONE polarized prescription lenses, VEL launched a new consumer website, coppertonelenses.com. On the website, consumers can learn more about the premium protection benefits and proven technology used in these products. Several videos educate consumers on the importance of sun protection and the dangers of HEV light and UV exposure. In addition to offering valuable product information, the website includes a provider lookup tool, allowing customers to locate COPPERTONE prescription sun lens providers in their area.
“The website is a larger platform to not only tell but show the quality of COPPERTONE lenses,” said Jay Lusignan, marketing communications manager at VEL. “Our interactive section has many unique features such as the “see the difference” section that shows the glare reduction COPPERTONE lenses provide, as well as a UV Index tool that provides consumers their local UV index.”
The site can be accessed directly at www.coppertonelenses.com or found in the consumer section of the VEL corporate website.